Patricia Aspichueta

机构：University of the Basque Country, Instituto de Salud Carlos III, BioCruces Health research Institute, Centro de Investigación Biomédica en Red, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Research Network (United States) · ORCID：0000-0002-3553-1755

发表论文 212 篇 · 总被引 5380 次 · h-index 42

代表论文

Cholangiocarcinoma 2026: status quo, unmet needs and priorities (2025 · Nature Reviews Gastroenterology & Hepatology · 被引 53)
Alcohol consumption in metabolic dysfunction-associated steatotic liver disease (MASLD): understanding the gut–liver crosstalk for clinical translation (2026 · Gut Microbes · 被引 5)
E2F2 transcription factor promotes a cholestatic MASH phenotype by regulating hepatobiliary metabolism through miR-34a-5p (2025 · Hepatology · 被引 3)
MARCO promotes cholangiocarcinogenesis by inducing immunosuppression and its targeting reduces tumor growth (2026 · Signal Transduction and Targeted Therapy · 被引 1)
Lipidomics uncovers metabolic manifestations related to liver steatosis and low-grade systemic inflammation in diet-treated hereditary fructose intolerance patients (2026 · Clinical Nutrition · 被引 1)
Statins halt polycystic liver disease by reprogramming metabolism and normalizing mitochondrial bioenergetics in cystic cholangiocytes (2026 · Hepatology · 被引 1)